• WuXi Biologics and WuXi STA Jointly Established WuXi XDC to Provide Fully Integrated Bioconjugate CDMO Services prnasia
    May 14, 2021
    WuXi Biologics, a global company with leading open-access biologics technology platforms, and WuXi STA, a subsidiary of WuXi AppTec, today announced that a joint venture company named WuXi XDC was established to provide end-to-end contract development ...
  • Applying Agile methodologies in CDMOs expresspharma
    May 14, 2021
    In order to truly help biotech and pharma companies in their journey from drug development to commercialisation, contract development and manufacturing organisations (CDMOs) have begun to incorporate the latest innovations in all aspects of their ...
  • Vetter, Rentschler Biopharma Advance Strategic Alliance contractpharma
    April 29, 2021
    ​Rentschler Biopharma and Vetter, two global CDMOs, have advanced their strategic collaboration, establishing a framework for their alliance and set up a governance structure, as well as implemented guidelines for their joint approach across functions.
  • Introducing ViroCell Biologics contractpharma
    April 29, 2021
    ViroCell Biologics, founded in the UK by a prolific academic viral vector manufacturing team, has officially launched. Viral vectors are the primary delivery method for innovative vaccines such as the Oxford/Astra Zeneca COVID vaccine, as well as ...
  • Biologics CDMO market to double in value by 2026, suggests report europeanpharmaceuticalreview
    April 16, 2021
    Research suggests the increasing R&D investment in and adoption of biologics will drive growth in the global biologics contract development and manufacturing organisation (CDMO) market.
  • Metrics Names Stephanie Emory Associate Director of Pharma Development contractpharma
    April 16, 2021
    ​Metrics Contract Services, the contract pharmaceutical development and manufacturing division of Mayne Pharma, has appointed Stephanie Emory, PhD as associate director of pharmaceutical development.
  • Recro, Ensysce Expand Development and Manufacturing Partnership contractpharma
    April 16, 2021
    ​Recro Pharma, a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges for companies developing oral solid dose drug products, has signed additional agreements with an existing ...
  • Ascendia Pharmaceuticals Poised for Expansion contractpharma
    April 12, 2021
    CDMO secures growth equity investment from Signet Healthcare Partners.
  • Recro Pharma Expands Business Development Team contractpharma
    April 06, 2021
    Recro Pharma Inc. has strengthened the company’s business development team to support its strategic objective of expanding and diversifying its customer base.
  • GRAM Attains EU GMP Certification for Commercial Aseptic Fill/Finish contractpharma
    March 31, 2021
    ​Grand River Aseptic Manufacturing (GRAM), an injectable CDMO, was recently audited by the Dutch Health and Youth Care Inspectorate (IGJ) and issued EU Good Manufacturing Practices (EU GMP) certificate.
PharmaSources Customer Service